Mobileye Global is a leading supplier of advanced driver-assistance systems (ADAS) and autonomous driving technology, best known for its EyeQ system-on-chip platform. Its quarterly results are closely watched as a barometer for ADAS adoption across the global automotive industry. Heading into the third quarter, the company had guided for a revenue decline, but stronger-than-expected EyeQ volume and rising SuperVision deliveries helped it outperform. Because Mobileye's technology is embedded across many of the world's largest automakers, its shipment trends offer investors a useful read on vehicle production, software content per vehicle, and the broader shift toward higher levels of driving automation. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Mobileye reported third quarter 2026 revenue of $492 million, down about 2.4% from $504 million in the same period last year but ahead of the roughly $477 million consensus estimate. The decline was driven primarily by a higher mix of Chinese OEM (original equipment manufacturer) shipments, which carry less software content and therefore lower pricing.
On the bottom line, adjusted (non-GAAP) earnings per share came in at $0.11, slightly above the $0.10 consensus and up from $0.09 a year earlier. Adjusted operating income increased approximately 20% year over year to $89 million, and adjusted operating margin expanded to about 18%, aided in part by an Israeli research and development (R&D) incentive that reduced qualifying R&D expenses. GAAP (generally accepted accounting principles) results continued to reflect a large non-cash goodwill impairment recognized earlier in 2026, which does not affect adjusted figures.
Management also raised its full-year 2026 revenue guidance, narrowing the range to $1.995 billion to $2.02 billion, implying roughly 5% to 7% growth for the year.
Sentiment into the report had been cautious, given management's prior guidance for a year-over-year revenue decline and broader uncertainty around global auto production. The results helped ease some of that concern: revenue topped consensus, adjusted EPS matched or slightly beat expectations, and the company raised its full-year outlook for the second time this year. Investors responded most to the resilience in EyeQ volumes, which grew while global vehicle production declined, and to the positive momentum in higher-value SuperVision and Surround ADAS programs. The stock's reaction will ultimately depend on how the market weighs near-term pricing pressure from Chinese OEM mix against the longer-term opportunity for higher content per vehicle.
Looking ahead, Mobileye's full-year 2026 revenue guidance now implies growth of roughly 5% to 7%, supported by EyeQ shipment volume that has consistently outpaced global auto production. A key watch item is the company's product mix: higher Chinese OEM shipments boost unit volume but carry lower average selling prices, so investors should monitor whether that pressure persists into 2027.
Another important factor is the trajectory of higher-value systems. Management now expects about 65,000 SuperVision deliveries for 2026 and continues to secure Surround ADAS and Cloud-Enhanced ADAS design wins with major automakers, including Volkswagen, Mahindra, and Stellantis. As these programs move into production over the next several years, they represent a path toward greater content per vehicle and improved pricing.
Investors should also track the contribution from the Israeli R&D incentive, which supported adjusted operating income in the third quarter but may be somewhat volatile quarter to quarter, as well as the company's progress in robotaxi commercialization and its recently acquired Mentee Robotics division. Cost discipline, operating cash flow, and any updates to the $250 million share repurchase program remain additional items worth following.
When following names like MBLY, I often turn to Tickeron’s AI tools to scan for comparable setups and monitor technical signals alongside the fundamentals. One platform I find particularly useful is the AI Screener, which lets me quickly filter across industries and patterns to see how a stock stacks up against peers. It helps surface ideas without replacing the core research process.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for MBLY turned positive on October 28, 2026. Looking at past instances where MBLY's MACD turned positive, the stock continued to rise in 28 of 33 cases over the following month. The odds of a continued upward trend are 85%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MBLY's RSI Oscillator exited the oversold zone, 23 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 31 of 46 cases where MBLY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
Following a +6.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where MBLY advanced for three days, in 163 of 215 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
MBLY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MBLY as a result. In 58 of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MBLY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for MBLY entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.664) is normal, around the industry mean (0.879). P/E Ratio (-1.290) is within average values for comparable stocks, (40.427). Projected Growth (PEG Ratio) (0.236) is also within normal values, averaging (1.471). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (3.164) is also within normal values, averaging (48.609).
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. MBLY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AutoPartsOEM